Development of novel clinical diagnostics and molecular medicines is key to fulfilling the promise of personalized medicine for treating cancer, heart disease, neurological disorders and other significant diseases. The identification of novel biomarkers based on disease-related genes, genetic mutations, and known genomes of infectious viruses and pathogens will require integrated technology platforms such as those developed at LC Sciences.
Personalized cancer treatment is being made possible by advanced diagnostic and informatics approaches that provide understanding of the molecular basis of disease.
Understanding the mechanisms that underlie diseases and disorders of the brain and central nervous system is crucial to developing treatments and diagnostic tests.
Identification of specific expression based signatures from peripheral blood or other biofluids that can act as biomarkers for various cardiac diseases / pathologies.
There is a urgent need for the development of novel and effective approaches for treatment of metabolic diseases such as diabetic nephropathy, obesity and osteoporosis.